1. Home
  2. RGEN vs BSAC Comparison

RGEN vs BSAC Comparison

Compare RGEN & BSAC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RGEN
  • BSAC
  • Stock Information
  • Founded
  • RGEN 1981
  • BSAC 1977
  • Country
  • RGEN United States
  • BSAC Chile
  • Employees
  • RGEN N/A
  • BSAC N/A
  • Industry
  • RGEN Medical/Dental Instruments
  • BSAC Commercial Banks
  • Sector
  • RGEN Health Care
  • BSAC Finance
  • Exchange
  • RGEN Nasdaq
  • BSAC Nasdaq
  • Market Cap
  • RGEN 8.2B
  • BSAC 9.0B
  • IPO Year
  • RGEN N/A
  • BSAC 1994
  • Fundamental
  • Price
  • RGEN $141.78
  • BSAC $20.55
  • Analyst Decision
  • RGEN Buy
  • BSAC Buy
  • Analyst Count
  • RGEN 10
  • BSAC 4
  • Target Price
  • RGEN $188.38
  • BSAC $20.48
  • AVG Volume (30 Days)
  • RGEN 934.6K
  • BSAC 223.0K
  • Earning Date
  • RGEN 10-29-2024
  • BSAC 10-30-2024
  • Dividend Yield
  • RGEN N/A
  • BSAC 3.68%
  • EPS Growth
  • RGEN N/A
  • BSAC 6.86
  • EPS
  • RGEN N/A
  • BSAC 0.00
  • Revenue
  • RGEN $602,354,000.00
  • BSAC $1,776,054,510.00
  • Revenue This Year
  • RGEN $0.08
  • BSAC N/A
  • Revenue Next Year
  • RGEN $12.97
  • BSAC $12.34
  • P/E Ratio
  • RGEN N/A
  • BSAC $16.02
  • Revenue Growth
  • RGEN N/A
  • BSAC 10.98
  • 52 Week Low
  • RGEN $110.45
  • BSAC $16.89
  • 52 Week High
  • RGEN $211.13
  • BSAC $21.19
  • Technical
  • Relative Strength Index (RSI)
  • RGEN 43.50
  • BSAC 54.15
  • Support Level
  • RGEN $138.80
  • BSAC $19.55
  • Resistance Level
  • RGEN $150.72
  • BSAC $20.43
  • Average True Range (ATR)
  • RGEN 4.98
  • BSAC 0.37
  • MACD
  • RGEN -0.92
  • BSAC -0.07
  • Stochastic Oscillator
  • RGEN 24.50
  • BSAC 61.48

About RGEN Repligen Corporation

Repligen Corp is a global life sciences company. It develops and commercializes innovative bioprocessing technologies and systems that increase efficiencies and flexibility in the process of manufacturing biological drugs. The company's customers include life science companies, global biopharmaceutical companies, and contract manufacturers worldwide. Repligen markets its products globally through a direct commercial organization in the U.S., Europe, and Asia, as well as through strategic partners in select markets. The majority of the company's revenue is generated in North America.

About BSAC Banco Santander - Chile ADS

Founded in 1978, Banco Santander Chile is part of the Santander group and majority controlled by Santander Spain. Banco Santander is the largest bank in Chile by loans and the second largest by deposits. The bank generates most of its net interest income (roughly 65% of total revenue) from its mortgage, unsecured consumer credit lines, and commercial loans. Banco Santander's commercial loan business is more focused on small- to medium-sized companies, with firms generating more than CLP 10,000 million in revenue only making up around 5% of outstanding loans. Outside of lending, Banco Santander is the largest card issuer in the country with around 25% of the market and benefits from a long-term strategic partnership with the largest airline in the country LATAM Chile.

Share on Social Networks: